trending Market Intelligence /marketintelligence/en/news-insights/trending/d6ttfukzod7ijbhxc06fga2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Rockwell Medical appoints CEO


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Rockwell Medical appoints CEO

Rockwell Medical Inc. appointed Stuart Paul as CEO.

The Wixom, Mich.-based biopharmaceutical company had fired its previous CEO and issued restraining orders against him. The company recently reached a settlement agreement with the former CEO and others.

Paul will take charge as CEO from Sept. 4 and will also become a board member. He last served as the corporate officer and vice president of Abbott Laboratories and was responsible for facilitating the acquisition of Alere Inc. by Abbott.

Rockwell focuses on developing therapies for kidney diseases and for patients undergoing dialysis.